Testing and shelf-life extension of USG-owned adjuvant for pandemic preparedness.

Ended Awarded Last action

Contract number
75A50119F33005
Awardee
Awarding agency
Obligated
$1,425,772

Award facts

Contract value 18% obligated
  • $1,425,772.07 Current, with exercised options
  • $7,935,685.07 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Montgomery Village, MD 20879, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 · The purpose of this bilateral modification is to deobligate $1,618,699.68 in unexpended funds from clins 001, 012, 013, and 014. -$1,618,700
Other Administrative Action P00012 · The purpose of this unilateral modification is to update the task order contracting officer to christopher weaver. $0
Terminate for Convenience P00011 · The purpose of this modification is to terminate the task order for convenience of the government. $0
Other Administrative Action P00010 · The purpose of this modification is to correct an administrative error made under modification P00009 in item 14. Description of amendment/modification $0
Funding Only Action P00008 · Descoping the general safety test from the stability protocol by DE obligating funding totaling $88,844.25, and update contractor's key personnel. -$88,844
Funding Only Action P00007 · For determination of residual carbonyl by dnph derivatization and RP-hplc under clin 0001B and to add a stability program for the adjuvant reference standard… $900,096
Funding Only Action P00006 · To correct price error in modification P0004 on clin 0004 and 0005 $0
Other Administrative Action P00005 · Replace contractor's key personnel $0
Supplemental Agreement for work within scope P00004 $33,250
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $2,199,970
Show all 13

About this award

Written by GovTribe AI ·

This is a $7,935,685.07 Cost Plus Fixed Fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, which is part of the U.S. Department of Health and Human Services, to Emergent Manufacturing Operations Baltimore LLC, a for-profit manufacturer of medical countermeasures. The contract is for testing and shelf-life extension of a U.S. Government-owned adjuvant for pandemic preparedness, under the Centers for Innovation in Advanced Development and Manufacturing program. The contract has a period of performance through December 18, 2023 and does not have a set-aside designation.

Quick answers

Who was awarded contract 75A50119F33005?

75A50119F33005 was awarded to Emergent Manufacturing Operations Baltimore LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on December 19, 2018.

How much is contract 75A50119F33005 worth?

The government has obligated $1,425,772 on 75A50119F33005. Its potential value, with all options, is $7,935,685.

Is contract 75A50119F33005 an order under another contract?

Yes. 75A50119F33005 is a delivery order under HHSO100201200004I, an indefinite delivery contract.

Was contract 75A50119F33005 competed?

The extent of competition for 75A50119F33005 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login